APA (7th ed.) Citation

Rikard, R. A., Chargualaf, L. M., Coulter, C., Weimer, E. T., Schmitz, J. L., Kotzen, E. S., . . . Szempruch, K. R. (2024). Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen. Wiley. https://doi.org/10.1111/ctr.15244

Chicago Style (17th ed.) Citation

Rikard, Rachel A., Laura M. Chargualaf, Carolyn Coulter, Eric T. Weimer, John L. Schmitz, Elizabeth S. Kotzen, Alyson Prom, Alexander H. Toledo, and Kristen R. Szempruch. Alemtuzumab Versus Anti‐thymocyte Globulin in Kidney Transplant Recipients Receiving a Rapid Steroid Withdrawal Regimen. Wiley, 2024. https://doi.org/10.1111/ctr.15244.

MLA (9th ed.) Citation

Rikard, Rachel A., et al. Alemtuzumab Versus Anti‐thymocyte Globulin in Kidney Transplant Recipients Receiving a Rapid Steroid Withdrawal Regimen. Wiley, 2024. https://doi.org/10.1111/ctr.15244.